Therapeutics
Oncology
Advancing Cancer Research Through Innovation
Recent advances in cancer immunotherapy have demonstrated unprecedented clinical benefits, offering hope of long-term remission—and even cure—for patients with advanced cancers. In step with this transformation in patient care, mediSMART is proud to be at the forefront of the evolving landscape of oncology drug development.
Our oncology research portfolio includes early-phase to late-phase clinical studies across a wide range of solid and hematological malignancies, such as:
🎗️ Breast cancer
🫁 Lung cancer
🔬 Gastric cancer
🧬 Hepatocellular carcinoma (HCC)
⚕️ Prostate cancer
🩸 Multiple myeloma
🔴 Acute myeloid leukemia (AML)
💉 Lymphoma
🧪 Leukaemia
With a strong network of investigators, study coordinators, and oncology experts, we support global sponsors and CROs in accelerating clinical trials with quality, speed, and regulatory compliance—from site selection to patient recruitment and study management.
Cardiovascular
Driving Innovation in Cardiovascular Research
Cardiovascular diseases remain a leading cause of mortality worldwide, driving an urgent need for innovative therapies that improve both quality and longevity of life. At mediSMART, we are committed to advancing cardiovascular health by supporting the development of cutting-edge treatments through high-quality clinical research.
Our team actively conducts phase I–IV clinical trials across a broad spectrum of cardiovascular indications, including:
❤️ Heart failure
🩺 Hypertension
🫀 Atherosclerosis
⚡ Acute coronary syndromes (ACS)
💔 Ischemic heart disease
🦵 Peripheral artery disease (PAD)
📈 Arrhythmias and atrial fibrillation
🧪 Hyperlipidemia and dyslipidemia
Backed by a robust network of cardiology investigators, dedicated study coordinators, and a strong operational infrastructure, mediSMART ensures efficient patient recruitment, regulatory adherence, and reliable data delivery across Turkey and the MENA region.
By partnering with global sponsors and CROs, we help bring life-saving cardiovascular therapies to patients faster—contributing to a healthier future for all.
Central Nervous System
Advancing Research in Central Nervous System Disorders
Central Nervous System (CNS) disorders are among the most complex and debilitating conditions, often requiring innovative approaches in both diagnosis and treatment. At mediSMART, we support the advancement of CNS drug development by delivering high-quality, patient-focused clinical research across Turkey and the MENA region.
Our experience spans phase I–IV clinical trials in a wide range of CNS indications, including:
🧠 Alzheimer's disease
🤝 Parkinson's disease
🔬 Multiple sclerosis (MS)
⚡ Epilepsy
🩺 Stroke and post-stroke recovery
🤕 Migraine
⚡ Neuropathic pain
😔 Major depressive disorder (MDD)
🧬 Schizophrenia and bipolar disorder
With access to specialized neurology and psychiatry investigators, experienced site personnel, and a growing network of CNS-focused study centers, mediSMART is equipped to meet the demands of complex protocols and long-term follow-up.
We understand the sensitivity and variability inherent in CNS studies and are committed to data quality, timely execution, and patient safety—helping sponsors bring forward the next generation of neurological and psychiatric therapies.
Endocrine & Metabolic Disorders
Supporting Innovation in Endocrine & Metabolic Disorders
The global rise in endocrine and metabolic diseases presents a major public health challenge—driving demand for novel therapies that improve long-term outcomes and patient quality of life. At mediSMART, we are actively involved in the clinical development of innovative treatments across a wide range of endocrine and metabolic indications.
We conduct phase I–IV clinical trials in both adult and pediatric populations, with experience in areas such as:
🩸 Type 1 and Type 2 diabetes mellitus
⚖️ Obesity and weight management
🧪 Dyslipidemia
🦋 Thyroid disorders
🧬 Adrenal and pituitary disorders
👩⚕️ Polycystic ovary syndrome (PCOS)
📏 Growth hormone deficiencies and metabolic bone diseases
Our dedicated team of endocrinology investigators, coordinators, and project managers ensures the smooth execution of complex, data-driven trials—with a strong focus on regulatory compliance, patient safety, and timely data delivery.
With a growing footprint across Turkey and the MENA region, mediSMART provides sponsors with localized expertise and regional scalability to advance clinical research in this critical therapeutic area.
Infectious Diseases
Tackling Global Health Challenges in Infectious Diseases
Infectious diseases continue to pose a significant burden on global health systems, requiring rapid innovation and resilient research frameworks. At mediSMART, we are committed to accelerating the development of preventive and therapeutic solutions through high-quality clinical trials in infectious diseases.
We support phase I–IV clinical studies across a wide spectrum of infectious disease areas, including:
🦠 COVID-19 and emerging viral infections
🧬 HIV/AIDS
🫀 Hepatitis B and C
🫁 Tuberculosis (TB)
🔬 Bacterial infections and antimicrobial resistance (AMR)
🍄 Fungal infections
💉 Vaccines for adults and pediatrics
✈️ Travel and tropical diseases
Our network includes infectious disease specialists, epidemiologists, and public health-focused research teams, ensuring comprehensive support from site activation to data collection and reporting.
mediSMART's operational excellence, regulatory expertise, and extensive reach across Turkey and the MENA region make us a reliable partner for global sponsors and CROs addressing urgent infectious disease threats.
Internal Medicine & Immunology
Advancing Research in Internal Medicine & Immunology
Internal medicine and immunology encompass a wide range of chronic, systemic, and immune-mediated conditions that demand careful clinical investigation and long-term patient management. At mediSMART, we bring together deep therapeutic expertise and operational excellence to support clinical trials across this diverse and complex field.
We conduct phase I–IV clinical studies in various internal medicine and immunology-related indications, including:
🦴 Rheumatoid arthritis (RA)
🔴 Systemic lupus erythematosus (SLE)
🫀 Inflammatory bowel disease (IBD) – Crohn's disease and ulcerative colitis
🧬 Psoriasis and psoriatic arthritis
🦴 Ankylosing spondylitis
🦋 Autoimmune thyroid disorders
⚡ Gout and other inflammatory conditions
🩺 General internal medicine indications (anemia, fatigue, chronic inflammatory states)
mediSMART collaborates with a network of rheumatologists, immunologists, gastroenterologists, and internal medicine specialists, providing full-service support from site selection to patient recruitment, monitoring, and data delivery.
With our strong presence in Turkey and the MENA region, we offer sponsors access to diverse patient populations, experienced research teams, and a commitment to delivering high-quality data on time and with integrity.